Key facts
- AdaptX’s last known valuation is $40.0M (Nov 2023).
- It has raised $23.1M across 3 recorded rounds; the latest was Seed Round ($2.7M) in Sep 2025.
- Notable investors include Alumni Ventures, Morningside Group, Cercano Management, WRF Capital, Memorial Hermann Foundation — 9 tracked in total.
- AdaptX has filed 3 Form Ds with the SEC since 2023, most recently Sep 2025 ($450K sold to 2 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for AdaptX
Funding rounds
3 roundsAbout AdaptX
Developer of a clinical healthcare analytics platform designed to visualize performance and compare approaches across patients, teams, and workflows. The company's platform combines algorithms, accesses an institution's existing electronic data, monitors and manages clinical data, and lets doctors define cohorts and select pertinent metrics revealing trends in the outcomes most relevant to their discipline through automated analytics, enabling healthcare service providers to improve the quality and safety of healthcare delivery.
- Sector
- Healthcare
- HQ
- Seattle, WA, United States
- Founded
- 2016
- Employees
- 39
- Website
- adaptx.com/
- Ownership
- Privately Held (backing)
AdaptX doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AdaptX shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AdaptX in its N-PORT filings yet. We sweep new filings monthly.